Increased GSAP mRNA expression with age supports previous findings that GSAP levels are significantly elevated in AD patient brain with severe pathology and cognitive deficits (Perez et al., 2017; Satoh et al., 2011; Zhu et al., 2014). The gene discussed is GSAP; the disease is Cognitive impairment.